ASCO Annual Meeting

2024 ASCO Annual Meeting

ODA-ASCO 2024-Andrea Wilson Woods_960x800
ODA-ASCO 2024-Morana Vojnic, MD, MBA_960x800
Fellows Forum-ASCO 2024-Jafar Al-Mondhiry, MD_960x800
ODA-ASCO 2024-Karan Jatwani, MBBS_960x800 (2)
Fellows Forum-ASCO 2024-Kareff, Haque, Hadfield_960x800
ODA-ASCO 2024-Karan Jatwani, MBBS_960x800
Fellows Forum-ASCO 2024-Muhammad Salman Faisal, MBBS_960x800
Fellows Forum-ASCO 2024-Playlist_960x800
ODA-ASCO 2024-Ofer Sharon, MD_960x800
1 2 3 4 5

2023 ASCO Annual Meeting

Dr. Jason Westin discusses results of the ZUMA-7 trial of axicabtagene ciloleucel for relapsed large B-cell lymphomas.
Dr. Deepa Rangachari discusses her team's medical cannabis training curriculum for hematology/oncology fellows.
Nina Morena and Ari Meguerditchian discuss their research encompassing the effects of social media on breast cancer patients.
Dr. Aamir Ehsan and Dr. Bridget Herschap discuss CorePath's HemePath Hub, pathology education for hematologic cancers.
Cassy Horton, Executive Director of Pickles Group, shares how they help support kids impacted by parental cancer.
At ASCO 2023, Barb Kunz, genetic counselor, discusses the impact of social determinants of health on TNBC genetic testing.
1 2 3 4

2022 ASCO Annual Meeting

Dr. Aamir Ehsan of CorePath Laboratories discusses how pathology can help personalize cancer diagnosis and treatment.
In this interview, Debra Lundquist, PhD, RN, talks about her and her colleagues poster presented at ASCO about patient-reported hope in EPCTs.
In this interview, Melissa Hudson, MD, discusses her study and insights into her research regarding long-term health outcomes for survivors of childhood cancer.
In this interview, Debra Lundquist talks about her ASCO presentations about patient-reported hope in early phase clinical trial participants.
1 2 3 4